Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nantkwest Inc CS (NQ: NK )

32.49 USD UNCHANGED
Last Price Updated: 7:37 PM EST, Mar 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 32.49
Bid (Size) 31.01 (3)
Ask (Size) 33.00 (1)
Prev. Close 32.49
Today's Range 32.49 - 32.49
52wk Range 2.920 - 45.42
Shares Outstanding 78,088,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ImmunityBio and NantKwest Complete Merger
ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing... 
From Business Wire News Releases
SHAREHOLDER ALERT: Barr Law Group Investigating NK, IQDNX, JELD, and MDXG; Shareholders are Encouraged to Contact the Firm
From GlobeNewswire News Releases

Performance

YTD
+136.64%
+136.64%
1 Month
N/A
N/A
3 Month
+126.57%
+126.57%
6 Month
+280.44%
+280.44%
1 Year
+934.71%
+934.71%

More News

Read More
Stockholders of NantKwest Approve Merger With ImmunityBio
From Business Wire News Releases
ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S.
From Business Wire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CTB, PBCT, HMSY, NK, SPWH
From PR Newswire
All Three Independent Proxy Advisory Firms – ISS, Glass Lewis and Egan-Jones – Recommend NantKwest Stockholders Vote “FOR” the Pending Merger With ImmunityBio
From Business Wire News Releases
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Merger Investigation
From GlobeNewswire News Releases
ImmunityBio Appoints John Brennan and Wesley Clark to Board of Directors
From Business Wire News Releases
Shanghai ImmuneOnco Raises $89 Million for Cancer Immunotherapies
From ChinaBio® Today
Cramer Advises Viewers On First Solar, Madison Square Garden Sports And More
Tags mad money Lightning Round Jim Cramer FICO
From Benzinga
AlphaBio In-licenses Off-the-Shelf NK/T-Cell Technology for Cancer
From ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.